新天药业：控股股东新天智药拟减持不超2.9962%公司股份

Group 1 - The controlling shareholder of the company, Shanghai Xintian Zhiyao Biotechnology Co., Ltd., plans to reduce its holdings by a total of no more than 7.05 million shares within three months from November 11, 2025, to February 10, 2026 [1] - The reduction will be executed through block trades and centralized bidding [1] - The shares to be reduced represent approximately 2.9962% of the total share capital after excluding shares held in the company's repurchase special account [1]